IL2 and type 1 diabetes mellitus: However, it was shown that in the NOD mouse model, adenoviral-driven IL2 overexpression promoted the selective proliferation and activation of Tregs while avoiding the activation of Teffs, which ultimately conferred protection against T1D development [24].